News
After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...
Eli Lilly & Co. said the U.S. attorney in Philadelphia has launched a civil investigation into the drug maker's marketing and promotional practices. Lilly said the products likely to be involved ...
Eli Lilly and Co. received a subpoena from the U.S. Department of Justice as part of an investigation into its manufacturing site in Branchburg, New Jersey, the company said in a statement to ...
Key Points President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports.Lilly's margins could be negatively affected if the company absorbs the higher costs.However, any ...
Michigan Attorney General Dana Nessel says a plain reading of state law shows her investigation into the price of insulin charged by Eli Lilly - is permissible.
Those were filed in January 2022 and challenged by Eli Lilly, launching the nearly two year court fight over the attorney general's authority to investigate Eli Lilly.
Notably, Eli Lilly's CEO attributes 45% of the Company's year-over-year revenue growth to strong sales of Zepbound and Mounjaro.
Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out poor manufacturing practices and data falsification involving ...
Michigan Attorney General Dana Nessel filed an application to appeal an order preventing her from investigating Eli Lilly and Company’s insulin pricing practices.
Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration's ban on the practice and luring people away from ...
Those were filed in January 2022 and challenged by Eli Lilly, launching the nearly two year court fight over the attorney general’s authority to investigate Eli Lilly.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results